These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Microalbuminuria: predictive factor of renal and cardiovascular risk]. Ruilope LM; Suárez C Rev Clin Esp; 1993 May; 192(9):415-6. PubMed ID: 8516504 [No Abstract] [Full Text] [Related]
5. Is sodium restriction important to hypertension? The argument against. Elijovich F J Clin Hypertens (Greenwich); 2004 Jun; 6(6):337-9. PubMed ID: 15187497 [No Abstract] [Full Text] [Related]
6. Effects of dietary modification on albumin excretion rate. Rahman M; Smith MC Am J Kidney Dis; 2009 Apr; 53(4):576-8. PubMed ID: 19324246 [No Abstract] [Full Text] [Related]
7. Salt intake and cardiovascular disease. He FJ; MacGregor GA Nephrol Dial Transplant; 2008 Nov; 23(11):3382-4; discussion 3385. PubMed ID: 18938265 [No Abstract] [Full Text] [Related]
8. [Nocturnal hypertension and cardio-renal association]. Kimura G Nihon Rinsho; 2014 Aug; 72(8):1404-9. PubMed ID: 25167743 [TBL] [Abstract][Full Text] [Related]
9. Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk. Ito S; Nagasawa T; Abe M; Mori T Hypertens Res; 2009 Feb; 32(2):115-21. PubMed ID: 19262469 [TBL] [Abstract][Full Text] [Related]
10. Potential societal savings from reduced sodium consumption in the U.S. adult population. Palar K; Sturm R Am J Health Promot; 2009; 24(1):49-57. PubMed ID: 19750962 [TBL] [Abstract][Full Text] [Related]
11. Biochemical risk markers: a novel area for better prediction of renal risk? Stuveling EM; Bakker SJ; Hillege HL; de Jong PE; Gans RO; de Zeeuw D Nephrol Dial Transplant; 2005 Mar; 20(3):497-508. PubMed ID: 15735241 [No Abstract] [Full Text] [Related]
12. Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study. Ninomiya T; Kiyohara Y; Tokuda Y; Doi Y; Arima H; Harada A; Ohashi Y; Ueshima H; Circulation; 2008 Dec; 118(25):2694-701. PubMed ID: 19106392 [TBL] [Abstract][Full Text] [Related]
13. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective. Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656 [TBL] [Abstract][Full Text] [Related]
14. Harmful effects of dietary salt in addition to hypertension. de Wardener HE; MacGregor GA J Hum Hypertens; 2002 Apr; 16(4):213-23. PubMed ID: 11967714 [TBL] [Abstract][Full Text] [Related]
15. Blood pressure variability in hypertension: a possible cardiovascular risk factor. Kario K Am J Hypertens; 2004 Nov; 17(11 Pt 1):1075-6. PubMed ID: 15533737 [No Abstract] [Full Text] [Related]
16. [Salt intake as a risk factor in the development of hypertensive organ damage]. Ando K Nihon Rinsho; 2004 Mar; 62 Suppl 3():60-4. PubMed ID: 15171342 [No Abstract] [Full Text] [Related]
17. Blood pressure salt sensitivity: a biomeasure of kidney disease susceptibility in diabetics? Weir MR Nephrol Dial Transplant; 2005 Oct; 20(10):2022-4. PubMed ID: 16030046 [No Abstract] [Full Text] [Related]
18. Metabolic syndrome: at the crossroads of cardiorenal risk. Natali A; Pucci G; Boldrini B; Schillaci G J Nephrol; 2009; 22(1):29-38. PubMed ID: 19229816 [TBL] [Abstract][Full Text] [Related]
20. The role of hypertension in the progression of renal diseases. Campese VM; Bigazzi R Am J Kidney Dis; 1991 May; 17(5 Suppl 1):43-7. PubMed ID: 2024672 [No Abstract] [Full Text] [Related] [Next] [New Search]